Pharma

By Laura Lovett 02:43 pm November 19, 2020
The femtech world is beginning to venture out of the boundaries of reproductive health and into other areas of women’s health, according to panelists at Bayer G4A summit yesterday.  Over the summer, Rock Health report that about 65% of all femtech funding has gone into fertility, pregnancy or motherhood. Today innovators are looking beyond the reproductive umbrella, at how technology and research...
Person checks medication online
By Laura Lovett 02:58 pm November 18, 2020
Pharma giant Bayer is kicking off new digital collaboration efforts in the fields of cardiometabolic and renal disease, oncology and women’s health via a new initiative, dubbed the G4A Digital Health Partnership Program.  The program is split into two tracks, one for early-stage companies and another for more experienced companies. It tapped Caria, an AI and data company that matches people...
Person with white jacket with AllianceRx logo speaks to another
By Laura Lovett 02:27 pm November 16, 2020
Home-delivery pharmacy AllianceRx Walgreens Prime is jumping into the oncology space with its new clinical assessment feature that lets cancer patients digitally manage their self-administered therapies. Specifically, the new feature lets patients with oncology conditions refill their prescriptions online as opposed to over the phone. The way it works is patients can log in to their account and...
Executives sign a contract.
By Dave Muoio 03:15 pm October 27, 2020
Life science technology and clinical trial data company Medidata announced today that it has acquired sensor maker MC10's digital biomarker business. The terms of the deal were not disclosed. WHAT'S THE IMPACT Medidata (a subsidiary of Dassault Systèmes) said the purchase will allow it to add biometric data and new analytics capabilities to its Patient Cloud platform, particularly to the benefit...
Pharma, machine learning, medical devices

Credit: BGU

By Rachel McArthur 11:20 am October 22, 2020
A new platform aimed at streamlining clinical trials in order to lower costs – and increase the efficiency and success rate of a drug or the development of a medical device – has been unveiled by Ben-Gurion University of the Negev (BGU). The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors including...
Example of the puzzle game display
By Dave Muoio 02:29 pm October 16, 2020
Back in April, Borderlands 3 – a big budget, role-playing first-person shooter videogame that sold over 8 million copies within six months of its release – received a free update that introduced a new mini-game to its players. Taking the form of a retro-style arcade cabinet in the home base's medical bay, "Borderlands Science" has players shifting colored blocks between rows and columns to solve...
A screenshot of Novartis's data42 initiative, shown during the company's HLTH presentation on digital strategy.
By Jonah Comstock 03:40 pm October 15, 2020
Novartis's digital strategy hasn't changed too much since MobiHealthNews spoke with the pharma company in 2018. But, at the HLTH virtual conference this week, Novartis Chief Digital Officer Betrand Bodson reiterated the company's four-part strategy, focusing especially on its partnerships, including those with Microsoft, Amazon and China's Tencent. "We started this agenda in earnest two and a...
COVID-19, middle east, Apps, Coronavirus, patient-centered care
By Dillan Yogendra 01:56 am September 30, 2020
The year 2020 will go down in history as one of the most challenging of our lifetime. Thinking back to January, none of us would have predicted the emergence of a pandemic-causing virus, let alone its devastating outcomes that have affected tens of millions of lives around the world so far. It has changed the way we do business, conduct events, and of course, report the news. Closer to home, we’...

Credit: Abbott

By Tammy Lovell 08:05 am September 21, 2020
Abbott announced that its Libre Sense Glucose Sport Biosensor has achieved a CE Mark, paving the way for a European roll-out.   The Libre Sense biosensor provides continuous glucose monitoring (CGM) to help athletes understand the efficacy of their nutrition choices on training and competition. Based on Abbott's FreeStyle Libre technology for people living with diabetes, it is the first personal-...
By Dave Muoio 04:53 pm September 11, 2020
International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia. The treatment, referred to as CT-155, will be a mobile app built on Click's proprietary tech platform, the companies said. Employing cognitive and neurobehavioral...